IMO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Energy Market UTI Q1 2026 Earnings EPS Misses Estimates but Stock Surges on Operational Momentum NP Q1 2026 Earnings EPS Falls Short of Estimates Yet Stock Gains AKTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus FSEA Q3 2024 Earnings Modest Profit Amid Narrowing Margins